Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022309

Expand all

ANDROGEL (TESTOSTERONE)
1.62% (20.25MG/1.25GM PACKET) Marketing Status: Prescription

Active Ingredient: TESTOSTERONE
Proprietary Name: ANDROGEL
Dosage Form; Route of Administration: GEL; TRANSDERMAL
Strength: 1.62% (20.25MG/1.25GM PACKET)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB2
Application Number: N022309
Product Number: 002
Approval Date: Sep 7, 2012
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ANDROGEL (TESTOSTERONE)
1.62% (40.5MG/2.5GM PACKET) Marketing Status: Prescription

Active Ingredient: TESTOSTERONE
Proprietary Name: ANDROGEL
Dosage Form; Route of Administration: GEL; TRANSDERMAL
Strength: 1.62% (40.5MG/2.5GM PACKET)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB2
Application Number: N022309
Product Number: 003
Approval Date: Sep 7, 2012
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ANDROGEL (TESTOSTERONE)
1.62% (20.25MG/1.25GM ACTUATION) Marketing Status: Prescription

Active Ingredient: TESTOSTERONE
Proprietary Name: ANDROGEL
Dosage Form; Route of Administration: GEL, METERED; TRANSDERMAL
Strength: 1.62% (20.25MG/1.25GM ACTUATION)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022309
Product Number: 001
Approval Date: Apr 29, 2011
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English